Pregled bibliografske jedinice broj: 405836
NSAIDs Consumption in Croatia : the Effects of Pricing Policy Changes
NSAIDs Consumption in Croatia : the Effects of Pricing Policy Changes // Abstracts of the Fourteenth Annual International Meeting of International Society for Pharmacoeconomics and Outcomes Research (ISPOR) ; u: Value in Health
Orlando (FL), Sjedinjene Američke Države, 2009. str. A73-A73 (poster, međunarodna recenzija, sažetak, znanstveni)
CROSBI ID: 405836 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
NSAIDs Consumption in Croatia : the Effects of Pricing Policy Changes
Autori
Vitezić, Dinko ; Madjarević, Tomislav ; Buble, Tonči ; Šestan, Branko ; Vitezić, Miomira ; Mršić Pelčić, Jasenka ; Župan, Gordana
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni
Izvornik
Abstracts of the Fourteenth Annual International Meeting of International Society for Pharmacoeconomics and Outcomes Research (ISPOR) ; u: Value in Health
/ - , 2009, A73-A73
Skup
Annual International Meeting of International Society for Pharmacoeconomics and Outcomes Research (14 ; 2009)
Mjesto i datum
Orlando (FL), Sjedinjene Američke Države, 16.05.2009. - 20.05.2009
Vrsta sudjelovanja
Poster
Vrsta recenzije
Međunarodna recenzija
Ključne riječi
non-steroidal anti-inflammatory drugs; financial expenditure; drug consumption; legal changes; pricing policy
Sažetak
The aim of this study was to detect changes in non-steroidal anti-inflammatory drugs (NSAIDs) financial expenditure and consumption according to the legal changes especially considering pricing policy (restrictive comparative pricing). Further, to analyze possible influences of new studies (connection between NSAIDs and increased cardiovascular risks) on NSAIDs utilization. The data was obtained from the Croatian National Health Insurance Institute and from pharmaceutical wholesalers for the seven-year period (2001-2007). Financial expenditure data are presented in Euros, while drug utilization data are presented in defined daily doses/1000 inhabitants/day (DDD/1000). In the investigated period the total expenditure of the group increased 10.39% while the related consumption of NSAID increased 1.95% (41.404 DDD/1000 to 42.224 DDD/1000). During the first part of the investigated period (from 2001-2005), before new pricing policy was introduced, the expenditure of NSAIDs increased 15.72% and the related consumption 5.92%. After the new measures were introduced (2005), in the period from 2005-2007 the financial expenditure of NSAIDs decreased 24.04% while usage decreased 4.03%. For the entire period diclofenac was the most frequently prescribed NSAID, but its share in the total consumption of NSAIDs decreased from 54.33 % in 2001 to 41.84% in 2007. The usage of NSAIDs in Croatia increased during the investigated period, so in 2005 new pricing policy was introduced to slow down the financial expenditure. This resulted in a considerable financial decrease and the usage was almost on the same level. The decrease of diclofenac usage in 2007 could be explained as the result of the published studies (the end of 2006) concerning its cardiovascular side effects.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti, Javno zdravstvo i zdravstvena zaštita
Napomena
Rad je rezultat zajedničkog rada na projektima 062-0620063-0060 i 062-0620063-0167.
POVEZANOST RADA
Projekti:
062-0620063-0060 - Uporaba kardiovaskularnih lijekova i značaj farmakoekonomskih procjena (Vitezić, Dinko, MZOS ) ( CroRIS)
062-0620063-0167 - Uporaba i potrošnja lijekova za liječenje bolesti koštano-mišićnog sustava (Šestan, Branko, MZOS ) ( CroRIS)
Ustanove:
Medicinski fakultet, Rijeka
Profili:
Branko Šestan
(autor)
Dinko Vitezić
(autor)
Jasenka Mršić-Pelčić
(autor)
Gordana Župan
(autor)
Tomislav Mađarević
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- Social Science Citation Index (SSCI)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE